[go: up one dir, main page]

GB0126389D0 - Wafer - Google Patents

Wafer

Info

Publication number
GB0126389D0
GB0126389D0 GBGB0126389.6A GB0126389A GB0126389D0 GB 0126389 D0 GB0126389 D0 GB 0126389D0 GB 0126389 A GB0126389 A GB 0126389A GB 0126389 D0 GB0126389 D0 GB 0126389D0
Authority
GB
United Kingdom
Prior art keywords
wafer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0126389.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Priority to GBGB0126389.6A priority Critical patent/GB0126389D0/en
Publication of GB0126389D0 publication Critical patent/GB0126389D0/en
Priority to PCT/IB2002/004142 priority patent/WO2003037395A1/fr
Priority to US10/285,072 priority patent/US20030099693A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/63—Crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0126389.6A 2001-11-02 2001-11-02 Wafer Ceased GB0126389D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0126389.6A GB0126389D0 (en) 2001-11-02 2001-11-02 Wafer
PCT/IB2002/004142 WO2003037395A1 (fr) 2001-11-02 2002-10-09 Pastille destinee a soigner des plaies
US10/285,072 US20030099693A1 (en) 2001-11-02 2002-10-30 Wafer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0126389.6A GB0126389D0 (en) 2001-11-02 2001-11-02 Wafer

Publications (1)

Publication Number Publication Date
GB0126389D0 true GB0126389D0 (en) 2002-01-02

Family

ID=9925065

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0126389.6A Ceased GB0126389D0 (en) 2001-11-02 2001-11-02 Wafer

Country Status (2)

Country Link
GB (1) GB0126389D0 (fr)
WO (1) WO2003037395A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE901838C (de) * 1948-10-02 1954-01-14 Heinz Ruether Dr Pflaster
EP0068149A3 (fr) * 1981-06-25 1983-07-20 Serapharm GmbH & Co. KG Préparation sêche contenant du fibrinogène, son obtention et utilisation
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
US5660854A (en) * 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
CN1284942A (zh) * 1998-01-09 2001-02-21 辉瑞大药厂 基质金属蛋白酶抑制剂
WO2000005214A2 (fr) * 1998-07-24 2000-02-03 Pfizer Inc. Isoquinoleines utilisees en tant qu'inhibiteurs de l'urokinase
GB9912961D0 (en) * 1999-06-03 1999-08-04 Pfizer Ltd Metalloprotease inhibitors
US20020022048A1 (en) * 2000-05-26 2002-02-21 Bromberg Lev E. Composite wafer for controlled drug delivery

Also Published As

Publication number Publication date
WO2003037395A1 (fr) 2003-05-08

Similar Documents

Publication Publication Date Title
IL154264A0 (en) Wafer prober
TW511649U (en) Wafer retainer
GB0112021D0 (en) Substrate
DE60228850D1 (en) Thermoplastisches transparentes acrylnitril-butadien-styrol-harz (abs-harz)
GB0126036D0 (en) Silicon compounds
AU2002360430A8 (en) 14-methyl-epothilones
AU2002357256A8 (en) Semiconductor apparatus
GB2394835B (en) Semiconductor structure
IL140936A0 (en) Chuck
AU2002313943A8 (en) Electromobile
GB0126389D0 (en) Wafer
AU2001100134A4 (en) Enviro-trap
AU2288P (en) Prime322 xTriticosecale
CA93647S (en) Fauteuil
CA93075S (en) Travelbag
CA93125S (en) Tilt-latch
AU2479P (en) Crackerjack xTriticosecale
CA93126S (en) Titlt-latch
CA92665S (en) Bedboard
CA92978S (en) Photo-changer
CA91502S (en) Bedboard
CA93646S (en) Fauteuil
CA93127S (en) Tilt-latch
GB0126598D0 (en) Semiconductor devices
GB0017493D0 (en) Flat wafer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)